Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
KIORA PHARMACEUTICALS INC See All Filings	D	2024-02-14 15:51:56 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers Maxim Group LLC CIK Number 0001372514 Filed Document 0001372514-24-000014 Exclusions or Exemptions 506b Accepted Date 2024-02-14 15:51:56 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
KIORA PHARMACEUTICALS INC See All Filings	D	2023-02-17 16:32:20 UTC
Amount To Be Raised $200,000 Associated Brokers / Dealers N/A CIK Number 0001372514 Filed Document 0001104659-23-023307 Exclusions or Exemptions 506b Accepted Date 2023-02-17 16:32:20 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
KIORA PHARMACEUTICALS INC See All Filings	D	2023-02-17 16:31:24 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers N/A CIK Number 0001372514 Filed Document 0001104659-23-023304 Exclusions or Exemptions 506b Accepted Date 2023-02-17 16:31:24 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
EYEGATE PHARMACEUTICALS INC See All Filings	D	2021-11-04 16:20:13 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001372514 Filed Document 0001104659-21-134407 Exclusions or Exemptions 506b Accepted Date 2021-11-04 16:20:13 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
EYEGATE PHARMACEUTICALS INC See All Filings	D	2021-01-21 16:15:27 UTC
Amount To Be Raised $8,000,003 Associated Brokers / Dealers N/A CIK Number 0001372514 Filed Document 0001104659-21-006310 Exclusions or Exemptions 506b Accepted Date 2021-01-21 16:15:27 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
EYEGATE PHARMACEUTICALS INC See All Filings	D	2020-12-31 19:51:06 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001372514 Filed Document 0001104659-20-141088 Exclusions or Exemptions 506b Accepted Date 2020-12-31 19:51:06 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
EYEGATE PHARMACEUTICALS INC See All Filings	D	2020-01-15 16:15:18 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001372514 Filed Document 0001104659-20-004326 Exclusions or Exemptions 506b Accepted Date 2020-01-15 16:15:18 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
EYEGATE PHARMACEUTICALS INC See All Filings	D	2019-10-08 16:06:12 UTC
Amount To Be Raised $1,875,000 Associated Brokers / Dealers N/A CIK Number 0001372514 Filed Document 0001144204-19-047664 Exclusions or Exemptions 506b Accepted Date 2019-10-08 16:06:12 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
EYEGATE PHARMACEUTICALS INC See All Filings	D	2016-07-07 16:16:45 UTC
Amount To Be Raised $3,768,750 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001372514 Filed Document 0001144204-16-112000 Exclusions or Exemptions 506b Accepted Date 2016-07-07 16:16:45 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
EYEGATE PHARMACEUTICALS INC See All Filings	D	2016-03-21 00:00:00 UTC
Amount To Be Raised $2,618,797 Associated Brokers / Dealers N/A CIK Number 0001372514 Filed Document 0001144204-16-089285 Exclusions or Exemptions 506b Accepted Date 2016-03-21 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
EYEGATE PHARMACEUTICALS INC See All Filings	D	2014-07-24 00:00:00 UTC
Amount To Be Raised $2,000,000 Associated Brokers / Dealers N/A CIK Number 0001372514 Filed Document 0001140361-14-029215 Exclusions or Exemptions 506b Accepted Date 2014-07-24 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Debt
EYEGATE PHARMACEUTICALS INC See All Filings	D	2013-09-26 00:00:00 UTC
Amount To Be Raised $1,448,264 Associated Brokers / Dealers N/A CIK Number 0001372514 Filed Document 0001140361-13-037049 Exclusions or Exemptions 506b Accepted Date 2013-09-26 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Debt